跳转至内容
Merck

X4753

Sigma-Aldrich

XCT790

≥98% (HPLC), solid

别名:

3-[4-(2,4-双-三氟甲基苄氧基)-3-甲氧基苯基]-2-氰基-N-(5-三氟甲基-1,3,4-噻二唑-2-基)丙烯酰胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C23H13F9N4O3S
分子量:
596.42
MDL號碼:
分類程式碼代碼:
12352202
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

solid

顏色

yellow

溶解度

DMSO: ≥10 mg/mL

儲存溫度

2-8°C

SMILES 字串

COc1cc(ccc1OCc2ccc(cc2C(F)(F)F)C(F)(F)F)\C=C(/C#N)C(=O)Nc3nnc(s3)C(F)(F)F

InChI

1S/C23H13F9N4O3S/c1-38-17-7-11(6-13(9-33)18(37)34-20-36-35-19(40-20)23(30,31)32)2-5-16(17)39-10-12-3-4-14(21(24,25)26)8-15(12)22(27,28)29/h2-8H,10H2,1H3,(H,34,36,37)/b13-6+

InChI 密鑰

HQFNFOOGGLSBBT-AWNIVKPZSA-N

應用

XCT790已被用于:
  • 在C2C12肌管中作为雌激素相关受体(ERR)α 的反向激动剂
  • 作为雌激素相关受体(ERR)α 反向激动剂以阐明ERR的蜕膜功能α 子宫内膜胚胎干细胞中
  • 作为人类神经母细胞瘤SH-SY5Y和HeLa细胞系中的自噬诱导剂。

生化/生理作用

XCT 790是一种5′腺苷单磷酸激活蛋白激酶(AMPK)激活剂。它还可充当线粒体中的质子离子载体和氧化磷酸化的解偶联剂。XCT790会破坏血管内皮生长因子(VEGF)和血管生成素2(Ang-2)的表达,并通过雌激素相关受体(ERRα)抑制表现出对子宫内膜肿瘤的抑制作用。XCT790可介导细胞周期停滞并促进三阴性乳腺癌(TNBC)的凋亡。
XCT790 是一种强效、特异性的 ERRα 反向激动剂。XCT790 具有选择性,在浓度低于 10 μM 时,对相关核受体(如 ERRγ 或 ERα)无明显拮抗活性。在使用 GAL4-ERR LBD 或全长 ERR 和 mSHP 启动子的瞬时转染试验中,IC 50 值为 300-500 nM。

危險聲明

防範說明

危險分類

Aquatic Chronic 4

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

G Vargas et al.
Oncogene, 38(7), 950-964 (2018-11-28)
Bone is the most common metastatic site for breast cancer. Estrogen-related-receptor alpha (ERRα) has been implicated in cancer cell invasiveness. Here, we established that ERRα promotes spontaneous metastatic dissemination of breast cancer cells from primary mammary tumors to the skeleton.
Banu Eskiocak et al.
Biochemistry, 53(29), 4839-4846 (2014-07-08)
XCT 790 is widely used to inhibit estrogen-related receptor α (ERRα) activity as an inverse agonist. Here, we report that XCT 790 potently activates AMP kinase (AMPK) in a dose-dependent and ERRα-independent manner, with active concentrations more than 25-fold below
Sin-Aye Park et al.
British journal of cancer, 123(6), 988-999 (2020-06-24)
Gremlin-1 (GREM1), one of the bone morphogenetic protein antagonists, is involved in organogenesis, tissue differentiation and kidney development. However, the role of GREM1 in cancer progression and its underlying mechanisms remain poorly understood. The role of GREM1 in breast cancer
LiLi Chen et al.
Aging, 12(17), 16963-16980 (2020-09-14)
PGC-1α and ERRα are closely related to tumor formation and progression. However, the mechanism underlying the involvement of PGC-1α/ERRα in regulating invasion and migration in endometrial cancer remains to be explored. Elevated levels of PGC-1α and ERRα were associated with
Zhenyu Xu et al.
Theranostics, 10(9), 4201-4216 (2020-04-01)
Enhanced intratumoral androgen biosynthesis and persistent androgen receptor (AR) signaling are key factors responsible for the relapse growth of castration-resistant prostate cancer (CRPC). Residual intraprostatic androgens can be produced by de novo synthesis of androgens from cholesterol or conversion from

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门